{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:04:28Z","timestamp":1792807468091,"version":"4.5.0"},"reference-count":105,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Govt. of India","doi-asserted-by":"publisher","award":["EX-DBT-5274-2022\/P357"],"award-info":[{"award-number":["EX-DBT-5274-2022\/P357"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Antibiotics, which hit the market with astounding impact, were once called miracle drugs, as these were considered the ultimate cure for infectious diseases in the mid-20th century. However, today, nearly all bacteria that afflict humankind have become resistant to these wonder drugs once developed to stop them, imperiling the foundation of modern medicine. During the COVID-19 pandemic, there was a surge in macrolide use to treat secondary infections and this persistent use of macrolide antibiotics has provoked the emergence of macrolide resistance. In view of the current dearth of new antibiotics in the pipeline, it is essential to find an alternative way to combat drug resistance. Antibiotic potentiators or adjuvants are non-antibacterial active molecules that, when combined with antibiotics, increase their activity. Thus, potentiating the existing antibiotics is one of the promising approaches to tackle and minimize the impact of antimicrobial resistance (AMR). Several natural and synthetic compounds have demonstrated effectiveness in potentiating macrolide antibiotics against multidrug-resistant (MDR) pathogens. The present review summarizes the different resistance mechanisms adapted by bacteria to resist macrolides and further emphasizes the major macrolide potentiators identified which could serve to revive the antibiotic and can be used for the reversal of macrolide resistance.<\/jats:p>","DOI":"10.3390\/antibiotics12121715","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T03:25:31Z","timestamp":1702265131000},"page":"1715","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-9408","authenticated-orcid":false,"given":"Deepjyoti","family":"Paul","sequence":"first","affiliation":[{"name":"Functional Genomics Laboratory, Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad 121001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Chawla","sequence":"additional","affiliation":[{"name":"Functional Genomics Laboratory, Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad 121001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8547-4948","authenticated-orcid":false,"given":"Taruna","family":"Ahrodia","sequence":"additional","affiliation":[{"name":"Functional Genomics Laboratory, Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad 121001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekshmi","family":"Narendrakumar","sequence":"additional","affiliation":[{"name":"Functional Genomics Laboratory, Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad 121001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabatosh","family":"Das","sequence":"additional","affiliation":[{"name":"Functional Genomics Laboratory, Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad 121001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lenz, K.D., Klosterman, K.E., Mukundan, H., and Kubicek-Sutherland, J.Z. (2021). Macrolides: From Toxins to Therapeutics. Toxins, 13.","DOI":"10.3390\/toxins13050347"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2666-5247(21)00173-7","article-title":"Rising antimicrobial resistance: An evolving epidemic in a pandemic","volume":"2","author":"Manesh","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e64139","DOI":"10.7554\/eLife.64139","article-title":"Antimicrobial resistance and COVID-19: Intersections and implications","volume":"10","author":"Knight","year":"2021","journal-title":"eLife"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40264-020-00976-7","article-title":"Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines","volume":"43","author":"Sultana","year":"2020","journal-title":"Drug Saf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2002606","article-title":"Macrolide and Non-macrolide Resistance with Mass Azithromycin Distribution","volume":"383","author":"Doan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","unstructured":"World Health Organization: WHO (2023, August 26). WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. Available online: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acsinfecdis.2c00121","article-title":"Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants","volume":"8","author":"Yu","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Narendrakumar, L., Chakraborty, M., Kumari, S., Paul, D., and Das, B. (2023). \u03b2-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1092556"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chawla, M., Verma, J., Gupta, R., and Das, B. (2022). Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.887251"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1016\/j.lansea.2022.100025","article-title":"Consumption of systemic antibiotics in India in 2019","volume":"4","author":"Koya","year":"2022","journal-title":"Lancet Reg. Health-Southeast Asia"},{"key":"ref_11","first-page":"1308","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider speciality in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kumar, M., Rao, M., Mathur, T., Barman, T.K., Joshi, V., Chaira, T., Singhal, S., Pandya, M., Al Khodor, S., and Upadhyay, D.J. (2021). Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.603151"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2014.11.008","article-title":"Azithromycin and ciprofloxacin: A possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections","volume":"45","author":"Saini","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.diagmicrobio.2009.10.013","article-title":"CEM-101, a novel fluoroketolide: Antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria","volume":"66","author":"Putnam","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2015.1136261","article-title":"Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin","volume":"43","author":"Gomes","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_16","unstructured":"Taylor, J.B., and Triggle, D.J. (2007). Comprehensive Medicinal Chemistry II, Elsevier."},{"key":"ref_17","unstructured":"Farzam, K., Nessel, T.A., and Quick, J. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/dkf013","article-title":"Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model","volume":"49","author":"Yanagihara","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"Dinos","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0924-8579(00)00315-0","article-title":"Antimicrobial activity and post-antibiotic effect of flurithromycin against Helicobacter pylori strains","volume":"17","author":"Fera","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1179\/joc.2004.16.2.151","article-title":"Comparison of Systemic Flurithromycin Therapy and Clinical Procedures in the Treatment of Periodontal Diseases","volume":"16","author":"Blandino","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41467-017-02680-0","article-title":"The evolution of substrate discrimination in macrolide antibiotic resistance enzymes","volume":"9","author":"Pawlowski","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Leroy, A.G., Caillon, J., Caroff, N., Broquet, A., Corvec, S., Asehnoune, K., Roquilly, A., and Cremet, L. (2021). Could Azithromycin Be Part of Pseudomonas aeruginosa Acute Pneumonia Treatment?. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.642541"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/AAC.01074-07","article-title":"Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation","volume":"52","author":"Wolter","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1345\/aph.1R435","article-title":"Cethromycin: A new ketolide antibiotic","volume":"47","author":"Mansour","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1592\/phco.30.3.290","article-title":"Cethromycin: A promising new ketolide antibiotic for respiratory infections","volume":"30","author":"Rafie","year":"2010","journal-title":"Pharmacotherapy."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1074\/jbc.RA119.010770","article-title":"A genome-wide analysis of targets of macrolide antibiotics in mammalian cells","volume":"295","author":"Gupta","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijantimicag.2017.05.020","article-title":"16-membered macrolide antibiotics: A review","volume":"51","author":"Arsic","year":"2018","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S1473-3099(18)30444-4","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: A systematic review","volume":"19","author":"Emerson","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Golkar, T., Zielinski, M., and Berghuis, A.M. (2018). Look and Outlook on Enzyme-Mediated Macrolide Resistance. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01942"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2013.05.012","article-title":"Which mechanisms of azithromycin resistance are selected when efflux pumps are inhibited?","volume":"4","author":"Gomes","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_32","first-page":"126","article-title":"Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: A systematic review with meta-analysis","volume":"64","year":"2012","journal-title":"Rev. Invest. Clin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"a025395","DOI":"10.1101\/cshperspect.a025395","article-title":"Resistance to Macrolide Antibiotics in Public Health Pathogens","volume":"6","author":"Fyfe","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/ijerph120201487","article-title":"Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens","volume":"12","author":"Andersen","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sharkey, L.K., Edwards, T.A., and O\u2019Neill, A.J. (2016). ABC-F Proteins Mediate Antibiotic Resistance through Ribosomal Protection. mBio, 7.","DOI":"10.1128\/mBio.01975-15"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Robin, B., Nicol, M., Le, H., Tahrioui, A., Schaumann, A., Vuillemenot, J.-B., Vergoz, D., Lesouhaitier, O., Jouenne, T., and Hardouin, J. (2022). MacAB-TolC Contributes to the Development of Acinetobacter baumannii Biofilm at the Solid\u2013Liquid Interface. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.785161"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2017.10.102","article-title":"Stoichiometry and mechanistic implications of the MacAB-TolC tripartite efflux pump","volume":"494","author":"Jo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Huang, L., Wu, C., Gao, H., Xu, C., Dai, M., Huang, L., Hao, H., Wang, X., and Cheng, G. (2022). Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview. Antibiotics, 11.","DOI":"10.3390\/antibiotics11040520"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/321001","article-title":"Structure and Dissemination of a Chromosomal Insertion Element Encoding Macrolide Efflux in Streptococcus pneumoniae","volume":"184","author":"Gay","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1128\/AAC.49.10.4203-4209.2005","article-title":"Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible","volume":"49","author":"Ambrose","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zwama, M., and Nishino, K. (2021). Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time. Antibiotics, 10.","DOI":"10.3390\/antibiotics10070774"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/jac\/dkl426","article-title":"Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF)","volume":"59","author":"Bohnert","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1021\/acs.chemrev.1c00055","article-title":"Structure, Assembly and Function of Tripartite Efflux and Type 1 Secrection Systems in Gram-negative Bacteria","volume":"121","author":"Alav","year":"2021","journal-title":"Chem. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Scoffone, V.C., Trespidi, G., Barbieri, G., Irudal, S., Perrin, E., and Buroni, S. (2021). Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens. Antibiotics, 10.","DOI":"10.3390\/antibiotics10070863"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Miklasinska-Majdanik, M. (2021). Mechanisms of Resistance to Macrolide Antibiotics among Staphylococcus aureus. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111406"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41467-021-22016-3","article-title":"Structural and functional insights into esterase-mediated macrolide resistance","volume":"12","author":"Zielinski","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dhindwal, P., Iryna Myziuk, I., and Ruzzini, A. (Trends Microbiol., 2023). Macrolide esterases: Current threats and opportunities, Trends Microbiol., in press.","DOI":"10.1016\/j.tim.2023.08.008"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/idr14010007","article-title":"Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case Report","volume":"14","author":"Merrick","year":"2022","journal-title":"Infect. Dis. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wu, Y., Battalapalli, D., Hakeem, M.J., Selamneni, V., Zhang, P., Draz, M.S., and Ruan, Z. (2021). Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. J. Nanobiotechnology, 19.","DOI":"10.1186\/s12951-021-01132-8"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kohler, T., Perron, G.G., Buckling, A., and van Delden, C. (2010). Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000883"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/sctm.20-0521","article-title":"Donor-defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacterium","volume":"10","author":"Bonfield","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s10311-021-01274-z","article-title":"The impact of human vaccines on bacterial antimicrobial resistance. A review","volume":"19","author":"Jansen","year":"2021","journal-title":"Environ. Chem. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"C43","DOI":"10.1016\/j.vaccine.2011.07.047","article-title":"The Future of Pneumococcal Disease Prevention","volume":"29","author":"Rodgers","year":"2011","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Gonzales, B.E., Mercado, E.H., Pinedo-Bardales, M., Hinostroza, N., Campos, F., Chaparro, E., Del \u00c1guila, O., Castillo, M.E., Saenz, A., and Reyes, I. (2022). Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.866186"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Eleraky, N.E., Allam, A., Hassan, S.B., and Omar, M.M. (2020). Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020142"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ejpb.2014.08.013","article-title":"Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method","volume":"88","author":"Morakul","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_61","first-page":"17","article-title":"Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different Gram-negative and Gram-positive bacteria","volume":"2","author":"Azhdarzadeh","year":"2012","journal-title":"Adv. Pharm. Bull."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chest.2018.11.006","article-title":"Effect of Combined beta-Lactam\/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia","volume":"155","author":"Ceccato","year":"2019","journal-title":"Chest"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/acsinfecdis.1c00147","article-title":"Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic","volume":"7","author":"Mood","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/INF.0000000000003559","article-title":"SOLI-PEDS Program. Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia","volume":"41","author":"Lang","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Blondeau, J.M. (2022). Immunomodulatory Effects of Macrolides Considering Evidence from Human and Veterinary Medicine. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122438"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1021\/acs.jmedchem.0c01506","article-title":"Proline Hinged Amphipathic \u03b1-Helical Peptide Sensitizes Gram-Negative Bacteria to Various Gram-Positive Antibiotics","volume":"63","author":"Hyun","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e01615-20","DOI":"10.1128\/mBio.01615-20","article-title":"Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance","volume":"11","author":"MacNair","year":"2020","journal-title":"mBio"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: A strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Du, D., Wang-Kan, X., Neuberger, A., van Veen, H.W., Pos, K.M., Piddock, L.J.V., and Luisi, B.F. (2018). Multidrug efflux pumps: Structure, function and regulation. Nat. Rev. Microbiol., 16.","DOI":"10.1038\/s41579-018-0048-6"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkp067","article-title":"Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter","volume":"63","author":"Jeon","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cbdd.12478","article-title":"Antibiotic adjuvants: Diverse strategies for controlling drug-resistant pathogens","volume":"85","author":"Gill","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(20)30868-9","article-title":"The urgent need for metallo-\u03b2-lactamase inhibitors: An unattended global threat","volume":"22","author":"Mojica","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/femsre\/fuz014","article-title":"Antibiotic resistance breakers: Current approaches and future directions","volume":"43","author":"Laws","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Klobucar, K., and Brown, E.D. (2022). New potentiators of ineffective antibiotics: Targeting the Gram-negative outer membrane to overcome intrinsic resistance. Curr. Opin. Chem. Biol., 66.","DOI":"10.1016\/j.cbpa.2021.102099"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1021\/acs.jmedchem.8b01781","article-title":"Antibiotic Adjuvants: Make Antibiotics Great Again!","volume":"62","author":"Douafer","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ramirez, D.M., Ramirez, D., Arthur, G., Zhanel, G., and Schweizer, F. (2022). Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria. Antibiotics, 11.","DOI":"10.3390\/antibiotics11101277"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Pandey, P., Sahoo, R., Singh, K., Pati, S., Mathew, J., Pandey, A.C., Kant, R., Han, I., Choi, E.H., and Dwivedi, G.R. (2021). Drug Resistance Reversal Potential of Nanoparticles\/Nanocomposites via Antibiotic\u2019s Potentiation in Multi Drug Resistant P. aeruginosa. Nanomaterials, 12.","DOI":"10.3390\/nano12010117"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mubeen, B., Ansar, A.N., Rasool, R., Ullah, I., Imam, S.S., Alshehri, S., Ghoneim, M.M., Alzarea, S.I., Nadeem, M.S., and Kazmi, I. (2021). Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics. Antibiotics, 10.","DOI":"10.3390\/antibiotics10121473"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.36.1.10","article-title":"Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum","volume":"36","author":"Pruul","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/1040841X.2019.1599813","article-title":"Antibiotic adjuvants: An alternative approach to overcome multi-drug resistant Gram-negative bacteria","volume":"45","author":"Liu","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13756-019-0559-6","article-title":"Review on plant antimicrobials: A mechanistic viewpoint","volume":"8","author":"Khameneh","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-9422(02)00446-6","article-title":"Bacterial resistance modifying agents from Lycopus europaeus","volume":"62","author":"Gibbons","year":"2003","journal-title":"Phytochemistry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.phytochem.2004.10.009","article-title":"Antibacterial and resistance modifying activity of Rosmarinus officinalis","volume":"65","author":"Oluwatuyi","year":"2004","journal-title":"Phytochemistry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00203-017-1378-x","article-title":"Modulation of the multidrug efflux pump EmrD-3 from Vibrio cholerae by Allium sativum extract and the bioactive agent allyl sulfide plus synergistic enhancement of antimicrobial susceptibility by A. sativum extract","volume":"199","author":"Bruns","year":"2017","journal-title":"Arch. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Siriyong, T., Srimanote, P., Chusri, S., Yingyongnarongkul, B., Suiasom, C., Tipmanee, V., and Voravuthikunchai, S.P. (2017). Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC Complement. Altern. Med., 17.","DOI":"10.1186\/s12906-017-1913-y"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1038\/s41598-017-03716-7","article-title":"Looking to nature for a new concept in antimicrobial treatments: Isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA","volume":"7","author":"Abreu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/acsinfecdis.9b00067","article-title":"Small Molecule Potentiation of Gram-Positive Selective Antibiotics against","volume":"5","author":"Martin","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ijantimicag.2018.10.025","article-title":"Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators","volume":"53","author":"Baker","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Baker, K.R., Jana, B., Hansen, A.M., Nielsen, H.M., Franzyk, H., and Guardabassi, L. (2019). Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination with Peptidomimetics. Front. Cell Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00236"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bmcl.2017.01.042","article-title":"Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1021\/acs.jmedchem.7b00453","article-title":"Identification and Structure-Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli","volume":"60","author":"Haynes","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acsinfecdis.8b00288","article-title":"Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa","volume":"5","author":"Hubble","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1021\/acsmedchemlett.0c00276","article-title":"Augmenting the Activity of Macrolide Adjuvants against","volume":"11","author":"Hubble","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Huan, Y., Kong, Q., Mou, H., and Yi, H. (2020). Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.582779"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-981-13-3588-4_15","article-title":"Clinical Application of AMPs","volume":"1117","author":"Costa","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"She, P., Liu, Y., Xu, L., Li, Y., Li, Z., Liu, S., Hussain, Z., and Wu, Y. (2022). SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant, Its Biofilms, and Persister Cells. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.858606"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","article-title":"Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus","volume":"92","author":"Sakoulas","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens","volume":"2","author":"Lin","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1039\/D0CS00102C","article-title":"Peptidomimetic toolbox for drug discovery","volume":"49","author":"Lenci","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Cui, Z.H., He, H.L., Zheng, Z.J., Yuan, Z.Q., Chen, Y., Huang, X.Y., Ren, H., Zhou, Y.F., Zhao, D.H., and Fang, L.X. (2023). Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria. Antibiotics, 12.","DOI":"10.3390\/antibiotics12040760"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"106053","DOI":"10.1016\/j.ijantimicag.2020.106053","article-title":"Macrolides and viral infections: Focus on azithromycin in COVID-19 pathology","volume":"56","author":"Pani","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ckj\/sfu098","article-title":"Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients","volume":"7","author":"Ma","year":"2014","journal-title":"Clin. Kidney J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11095-019-2582-y","article-title":"Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling","volume":"36","author":"Woodhead","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_104","first-page":"164","article-title":"Pharm GKB summary: Macrolide antibiotic pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharm. Genet. Genom."},{"key":"ref_105","first-page":"229","article-title":"Peptidomimetics as a new generation of antimicrobial agents: Current progress","volume":"7","year":"2014","journal-title":"Infect. Drug Resist."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/12\/1715\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:36:25Z","timestamp":1760132185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/12\/1715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":105,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["antibiotics12121715"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12121715","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]}}}